Status:

RECRUITING

A Randomized Controlled Trial of LOT-CRT Versus conventionaL BiVP in Heart Failure Patients With NICD

Lead Sponsor:

The First Affiliated Hospital with Nanjing Medical University

Collaborating Sponsors:

Shanghai Zhongshan Hospital

Sir Run Run Shaw Hospital

Conditions:

Heart Failure

Intraventricular Block

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

BATTLE study has been designed as a prospective, multi-center, randomized, controlled trial. This study will enroll 83 patients with chronic heart failure accompanied by intraventricular block (NICD) ...

Detailed Description

Cardiac resynchronization therapy is a standardized treatment strategy for patients with chronic heart failure complicated by wide QRS waves. With the continuous development of physiological pacing te...

Eligibility Criteria

Inclusion

  • Ischemic or non ischemic cardiomyopathy
  • Optimal medical therapy for at lest 3 months
  • NYHA class II-IV
  • LVEF≤35% as assessed by echocardiography
  • Sinus rhythm (may have paroxysmal atrial fibrillation)
  • QRS duration ≥ 150ms
  • Intraventricular block (NICD), QRS morphology is neither LBBB nor RBBB

Exclusion

  • Valvular heart disease that requires or has undergone surgical intervention
  • After mechanical tricuspid valve replacement
  • Persistent or permanent atrial fibrillation or atrial flutter
  • Second or third degree atrioventricular block
  • Have a history of acute myocardial infarction within 3 months prior to enrollment
  • Patient's expected survival time is less than 12 months
  • Pregnant or planned to conceive
  • Ventricular septal hypertrophy (ventricular septal thickness exceeds 15mm at the end of diastole)
  • Patients with simple and persistent left superior vena cava
  • Patients with existing pacemaker implantation

Key Trial Info

Start Date :

September 21 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2027

Estimated Enrollment :

86 Patients enrolled

Trial Details

Trial ID

NCT06061627

Start Date

September 21 2023

End Date

March 1 2027

Last Update

March 13 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The First Affiliated Hospital with Nanjing Medical University

Nanjing, Jiangsu, China, 210029